Menu

Sam Meiklejohn focuses his practice primarily on equity capital markets and public companies. Sam advises corporates, major shareholders and investment banks on primary and secondary securities offerings listed on UK and international stock exchanges. Sam also has experience in debt capital markets, and has advised a range of companies and investment banks on their issuances of high yield bonds and EMTN programmes. Sam has worked extensively on cross-border and international transactions, both transatlantic and across the MENA region working for six months in Abu Dhabi during 2014.

Download full bio 

Experience

  • Silence Therapeutics – $56.5 Million Registered Direct Offering 

  • Grindr Agrees to Merge With SPAC Tiga Acquisition Corp. 

  • Thayer Ventures Acquisition Corp. Completes Merger With Inspirato 

  • Centessa Pharmaceuticals – $380 Million IPO 

  • Immunocore – $297 Million IPO 

  • View all

Education

  • College of Law
    LPC, 2013

  • BPP University Law School
    GDL, 2012

  • University of Leeds
    BA (Hons) History, First Class, 2011


Admissions & Credentials

England & Wales